NCT06505447 PICU-related Sleep and Circadian Dysregulation Pilot Study
| NCT ID | NCT06505447 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York at Buffalo |
| Condition | Circadian Dysrhythmia |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-12-06 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-12-06 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.
Eligibility Criteria
Inclusion Criteria: 1. Child age 3 to 6 years old on the day of PICU admission 2. English-speaking parent at the bedside 3. Child expected to remain in the PICU over 24 to 48 hours Exclusion Criteria: 1. Child is in end-of-life care 2. The child is receiving neuromuscular blockade for any reason 3. Caregiver or parent not at the bedside
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06505447 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 6 Years, studying Circadian Dysrhythmia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06505447 currently recruiting?
Yes, NCT06505447 is actively recruiting participants. Contact the research team at albrooks@buffalo.edu for enrollment information.
Where is the NCT06505447 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT06505447 clinical trial?
NCT06505447 is sponsored by State University of New York at Buffalo. The trial plans to enroll 30 participants.